نتایج جستجو برای: ژن hbsag

تعداد نتایج: 20716  

2013
WANZHUO XIE DE ZHOU KEYUE HU XIBIN XIAO WEIJIA HUANG JINSONG HE JIMIN SHI YI LUO JIE ZHANG MAOFANG LIN ZHEN CAI HE HUANG XIUJIN YE

The aim of this study was to analyze the clinical features of hepatitis B surface antigen (HBsAg)-positive and negative diffuse large B-cell lymphomas (DLBCLs) and to compare the outcomes and serum hepatitis B virus (HBV)-DNA loads of patients treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) regimens with rituximab (RCHOP) or without. A total of 451 DLBCL patients, ...

2014
Mei-Zhu Hong Wen-Qi Huang Feng Min Jin-Chao Xu Zhen Lin Kuang-Nan Fang Jin-Shui Pan

BACKGROUND AND AIMS Little is known about whether low serum HBsAg levels result from impaired HBsAg synthesis or a reduced number of hepatocytes caused by advanced liver fibrosis. Therefore, we investigated the capacity for HBsAg synthesis in a cross-sectional cohort of treatment-naïve chronic hepatitis B patients. METHODS Chronic hepatitis B patients (n = 362) were enrolled; liver biopsies w...

Journal: :Journal of virological methods 2004
Matsuo Deguchi Naoko Yamashita Masanori Kagita Seishi Asari Yoshinori Iwatani Takahiko Tsuchida Kazushige Iinuma Isa K Mushahwar

A fully automated chemiluminescent microparticle immunoassay (Architect HBsAg QT) was used for the detection and quantitation of hepatitis B surface antigen (HBsAg). The assay is capable of processing up to 800 HBsAg tests per hour. The concentration of HBsAg is determined by utilizing a previously generated Architect HBsAg calibration curve. Architect HBsAg QT sensitivity was found to be aroun...

Journal: :BMC Infectious Diseases 2006
Vasilios German Georgios Giannakos Petros Kopterides Konstantinos Liaskonis Matthew E Falagas

BACKGROUND The prevalence of hepatitis B virus infection in Greece has been decreasing over the last decades. However, recent epidemiological data are lacking. METHODS We studied 1,840 Army recruits from 05/2004 until 10/2005, and performed serological testing for HBsAg, anti-HBsAg, and anti-HBcAg. We also examined their association with several factors, including age, residential area, socio...

2017
Yunsong Li Qun Cai Qinxiu Xie Yafei Zhang Xiangling Meng Zhenhua Zhang

BACKGROUND The aim of this study was to characterize the expression and secretion of hepatitis B surface-antigen (HBsAg) in the hepatocytes of hepatitis B virus (HBV)-infected patients at different phases of infection; as such, the association of intrahepatic HBsAg expression with virological markers and the histological characteristics were analyzed. MATERIAL AND METHODS 302 chronic HBV infect...

Journal: :Antiviral therapy 2013
R Bart Takkenberg Louis Jansen Annikki de Niet Hans L Zaaijer Christine J Weegink Valeska Terpstra Marcel G W Dijkgraaf Richard Molenkamp Peter L M Jansen Maarten Koot Vincent Rijckborst Harry L A Janssen Marcel G H M Beld Hendrik W Reesink

BACKGROUND In this study, we aimed to identify baseline predictors of response in chronic hepatitis B patients treated with a combination of pegylated interferon (PEG-IFN)-α2a and adefovir. METHODS We treated 92 chronic hepatitis B patients (44 hepatitis B e antigen [HBeAg]-positive and 48 HBeAg-negative) with HBV DNA > 100,000 copies/ml (> 17,182 IU/ml) with PEG-IFN and adefovir for 48 weeks...

2015
Maria Belopolskaya Viktor Avrutin Sergey Firsov Alexey Yakovlev

BACKGROUND Viral load measurement is necessary to estimate mother-to-child transmission risk for women with chronic hepatitis B (CHB), however, it is expensive. The present study aimed to investigate the relationship between HBsAg and hepatitis B virus (HBV) DNA levels, and to determine potential applications of HBsAg level monitoring for estimating viral load. METHODS 85 patients with CHB (3...

Journal: :Antiviral therapy 2008
Johannes Wiegand Heiner Wedemeyer Andrea Finger Benjamin Heidrich Jens Rosenau Gerd Michel C Thomas Bock Michael P Manns Hans L Tillmann

BACKGROUND The elimination of hepatitis B virus surface antigen (HBsAg) is the final goal of hepatitis B treatment, but is rarely achieved. As quantitative assays for HBsAg recently became available, we have investigated whether quantitative HBsAg measurements can substitute for hepatitis B virus (HBV) DNA quantification in treatment monitoring. METHODS Within this study, 23 liver transplant ...

2012
Edouard Tuaillon Anne-Marie Mondain Nicolas Nagot Laure Ottomani Dramane Kania Erika Nogue Pierre-Alain Rubbo Georges-Philippe Pageaux Philippe Van de Perre Jacques Ducos

BACKGROUND The decline in hepatitis B virus surface antigen (HBsAg) may be an early predictor of the viral efficacy of Hepatitis B virus (HBV) therapy. The HBsAg levels obtained by different immunoassays now need comparing and the relationships between levels of HBsAg and HBV DNA alongside HBsAg and genotype must be evaluated. METHODOLOGY/PRINCIPAL FINDINGS HBsAg levels were compared among 80...

Journal: :The Journal of infectious diseases 2009
Ming-Lung Yu Chuan-Mo Lee Wan-Long Chuang Sheng-Nan Lu Chia-Yen Dai Jee-Fu Huang Zu-Yau Lin Tsung-Hui Hu Chien-Hung Chen Chao-Hung Hung Jin-Houng Wang Chi-Ling Chen Jia-Horng Kao Ming-Yang Lai Chen-Hua Liu Tung-Hung Su Shun-Sheng Wu Li-Ying Liao Hsing-Tao Kuo You-Chen Chao Shui-Yi Tung Sien-Sing Yang Pei-Jer Chen Chun-Jen Liu Ding-Shinn Chen

BACKGROUND With use of peginterferon alfa-2a and ribavirin combination therapy in patients with dual chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, 11.2% of patients achieved clearance of hepatitis B surface antigen (HBsAg) at 6 months after treatment; however, reactivation of HBV DNA was observed in 36.3%. We investigated the predictive potential of HBsAg quantification...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید